News

As a vice president of Corporate Development, Xing Shen will oversee the company’s strategic business development and internal investor relations functions. Prior to his tenure with Lotus Pharma,

Most recently, Cohen worked as the chief scientific officer in Rosetta Genomics, a developer of microRNA-based molecular diagnostics. Asterand CEO Martyn Coombs said that Cohen has a reputation

As per the extended agreement, Pfizer is expected to continue to fund all aspects of the collaboration including research efforts at both companies and all clinical development costs

As per the terms of the agreement, Lonza is expected to market Scarab Genomics’Clean Genome technology, giving Lonza customers full access to the platform for protein and plasmid

Medtronic said that the findings include one-year results for Resolute International, two subsets from Resolute All Comers, and four-year results for the Resolute feasibility study, which supported the

Bardoxolone methyl, which is currently in late Phase 2 trials, is an oral, antioxidant inflammation modulator that works by increasing the estimated glomerular filtration rate (eGFR) of the

The recall has been initiated by Abbott following an internal quality review, which detected the remote possibility of the presence of a small common beetle in the product

The Apposition II trial involved 80 patients and was conducted in 6 European countries, between December 2009 and June 2010, which compares the Stentys self-apposing stent with a

Menerba is an oral, botanically-derived estrogen receptor beta (ER-b) selective drug candidate designed for the safe, effective treatment of vasomotor symptoms (hot flashes) associated with menopause. With this